 HealthNewsDigest.com | Older and Younger Chronic Leukemia Patients May Need Different Therapy HealthNewsDigest.com "The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age," says Byrd, who is the D. Warren Brown ... |
